Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Interim Management Statement

21 May 2010 07:00

RNS Number : 3118M
S & U PLC
21 May 2010
Β 

ο»Ώ

21 May 2010

Β 

Interim Management Statement

Β 

Β 

Β 

S&U, Britain's foremost niche home credit and motor finance provider, today issues an interim management statement for the period from 1 February 2010 to 20 May 2010, ahead of its Annual General Meeting being held later today.

Β 

Home Credit

Loansathome4u, our home credit business, increased revenues by 2% in this period versus the same period last year which reflects a 4% growth in customer numbers offset by continued customer borrowing caution in the current economic climate. Collections have remained robust, being up by over 3% on last year with impairment charges being reduced by 2%. These results are testimony to the well-established and mutually beneficial relationships our representatives have with our customers. Administrative expenses are stable but will reflect an extra Β£350,000 charge in the first half year due to accelerated remuneration payments made before the Government tax legislation changes at the end of March 2010. This Β£350,000 charge will reverse in the second half year.

Β 

Motor Finance

Advantage, our motor finance business, has followed up on a strong finish to the last financial year with an excellent start to this financial year. In a less competitive market, new business written is up over 40% on the same period last year and initial repayment quality continues to be higher in line with recent trends. Revenues are up over 20% on the same period last year, whilst impairment charges have only risen by 11% and overall collections are good. Early redemptions continue to be lower than last year and current levels of profitability are encouraging.

Β 

Funding and Capital

S&U's financial position is strong and becoming stronger. Since the year end Group borrowings have been reduced to Β£26.1m (May 2009: Β£27.6m) as the trading cash generated has more than funded good motor finance growth and covered Β£2.4m of accelerated dividend and remuneration payments made in the first quarter. We anticipate that Group borrowings should reduce further in the second quarter, increasing the likely headroom available for further organic growth and acquisition.

Β 

Outlook

S&U is cautiously optimistic about the outlook and is trading in line with its expectations for the year to date.

Β 

S&U will issue a further trading update following its half year ending 31 July 2010. The interim results are scheduled for release towards the end of September 2010.

Β 

Commenting, Mr Anthony Coombs, S&U Chairman, said:

Β 

"Whilst economic conditions will take time to become more certain, the resilience of our own performance and current positive trading trends give cause for continued cautious optimism."

Β 

For further information, please contact:

Β 

S&U plc www.suplc.co.ukΒ 

Anthony Coombs, Chairman 0121 705 7777

Β 

Charles Stanley Securities

Mark Taylor / Dugald Carlean 020 7149 6000

Β 

Smithfield

Rupert Trefgarne/ Rebecca Whitehead 020 7360 4900

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSMMGZKLGZGGZM
Date   Source Headline
13th Apr 20174:24 pmRNSAnnual Financial Report
28th Mar 20177:00 amRNSFinal Results
10th Feb 20177:00 amRNSTrading Statement
19th Dec 20163:42 pmRNSDirector/PDMR Shareholding
14th Dec 201610:40 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSTrading Statement
6th Dec 201611:26 amRNSDirector/PDMR Shareholding
29th Nov 201612:40 pmRNSDirector/PDMR Shareholdings
29th Nov 201610:47 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20163:36 pmRNSExercise and Sale of Options
19th Oct 201612:43 pmRNSDirector/PDMR Shareholding
27th Sep 20167:00 amRNSHalf-year Report
5th Aug 20167:00 amRNSTrading Statement
26th Jul 20164:41 pmRNSSecond Price Monitoring Extn
26th Jul 20164:35 pmRNSPrice Monitoring Extension
8th Jul 201611:30 amRNSDirector/PDMR Shareholding
22nd Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 20167:00 amRNSAnalyst Day 2016
9th Jun 201611:22 amRNSExercise and Sale of Options
27th May 20163:25 pmRNSDirector/PDMR Shareholding
26th May 20163:20 pmRNSBlock Listing Six Monthly Return
17th May 201612:41 pmRNSResult of AGM
17th May 20167:00 amRNSAGM Statement & Trading Update
3rd May 20169:13 amRNSTotal Voting Rights
15th Apr 20162:49 pmRNSAnnual Report and Accounts
13th Apr 20162:29 pmRNSExercise & Sale of Options/ Directors Shareholding
6th Apr 20164:49 pmRNSDirector/PDMR Shareholding
4th Apr 201612:38 pmRNSBlock Listing Application
22nd Mar 20167:00 amRNSAppointment of Non-Executive Director
22nd Mar 20167:00 amRNSPreliminary Results for Year Ended 31 January 2016
12th Feb 20167:00 amRNSTrading Update
15th Jan 20165:13 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSRe: Options/ Directors' shareholding
11th Dec 20153:35 pmRNSDirector/PDMR Shareholding
10th Dec 20157:00 amRNSTrading Statement
23rd Nov 20157:00 amRNSBlocklisting Six Monthly Return
28th Sep 20155:33 pmRNSRe: Options/ Directors' Shareholding
22nd Sep 20157:00 amRNSHalf Yearly Report
5th Aug 20157:00 amRNSTrading Statement
4th Aug 20151:18 pmRNSCompletion of Disposal and Director Shareholding
3rd Aug 201512:00 pmRNSResult of General Meeting
9th Jul 20155:16 pmRNSPosting of Circular
7th Jul 201512:45 pmRNSDisposal
26th May 201512:54 pmRNSBlock Listing Application
26th May 201512:51 pmRNSBlocklisting Interim Review
21st May 20152:23 pmRNSAGM Statement
21st May 20157:00 amRNSInterim Management Statement
17th Apr 20157:00 amRNSAnnual Financial Report
1st Apr 201512:58 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.